FERMT2 and colorectal carcinoma: Generally, the CRC patients with higher FERMT2 expression had significantly shorter overall survival (OS), disease-free survival (DFS) and disease-specific survival (DSS) compared to those with lower FERMT2 expression in GSE17536 (209209_s_at) cohorts (Fig 2A–2C).